Order Article Reprints

Kette S, Reccardini N, Salton F, Confalonieri P, Andrisano A, Chianese M, De Nes A, Maggisano M, Galantino A, Nicolosi S, et al. The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis. Pharmaceuticals. 2025; 18(3):411. https://doi.org/10.3390/ph18030411

Kette, Stefano, Nicolò Reccardini, Francesco Salton, Paola Confalonieri, Alessia Andrisano, Maria Chianese, Anna De Nes, Marta Maggisano, Alessandra Galantino, Salvatore Nicolosi, and et al. 2025. "The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis" Pharmaceuticals 18, no. 3: 411. https://doi.org/10.3390/ph18030411

Kette, S., Reccardini, N., Salton, F., Confalonieri, P., Andrisano, A., Chianese, M., De Nes, A., Maggisano, M., Galantino, A., Nicolosi, S., Mari, M., Salotti, A., Angoni, D., Chernovsky, M., Hughes, M., Confalonieri, M., Mondini, L., & Ruaro, B. (2025). The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis. Pharmaceuticals, 18(3), 411. https://doi.org/10.3390/ph18030411